A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors.
about
Update on aurora kinase inhibitors in gynecologic malignancies.Update on Aurora Kinase Targeted Therapeutics in Oncology.Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.Aurora kinase inhibitors: progress towards the clinicA phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia.The Aurora kinase inhibitors in cancer research and therapy.An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies.
P2860
Q34576017-434E09D7-8147-4531-AF3D-B2080F99B333Q34941504-2615F0FB-6EAD-43F9-B849-6925D3BABDC6Q37565470-E3C21321-7E4D-4A85-B168-07C7822BB9EBQ37986455-ACB35B40-49DE-475E-B5FC-DDB9BCF751B9Q38735991-7A2266B0-EDAD-4573-8D1B-A4B483D555AEQ38756932-38EF4EDB-B817-48FC-A785-1AF4AE681033Q38783162-5D3C1B10-A7FA-4AC4-9EFA-F2FEFB625B4EQ39001858-201B098E-0601-41E8-B453-0FB8430591CC
P2860
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A phase I study of MK-5108, an ...... ed or refractory solid tumors.
@ast
A phase I study of MK-5108, an ...... ed or refractory solid tumors.
@en
type
label
A phase I study of MK-5108, an ...... ed or refractory solid tumors.
@ast
A phase I study of MK-5108, an ...... ed or refractory solid tumors.
@en
prefLabel
A phase I study of MK-5108, an ...... ed or refractory solid tumors.
@ast
A phase I study of MK-5108, an ...... ed or refractory solid tumors.
@en
P2093
P2860
P1476
A phase I study of MK-5108, an ...... ed or refractory solid tumors.
@en
P2093
A Craig Lockhart
Andrea Wang-Gillam
Cheryl A Pickett
Darcy Hille
David Mauro
Jared Lunceford
Lauren Trull
Manik Amin
Mark N Stein
Patricia M LoRusso
P2860
P2888
P356
10.1007/S10637-015-0306-7
P577
2015-12-01T00:00:00Z